Stay updated on Nivolumab vs Docetaxel in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Docetaxel in Lung Cancer Clinical Trial page.
Latest updates to the Nivolumab vs Docetaxel in Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying who to contact for questions and providing information on the study's location, with a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference2%
- Check48 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference2%
- Check55 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.0%
- Check63 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.SummaryDifference0.1%
Stay in the know with updates to Nivolumab vs Docetaxel in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Docetaxel in Lung Cancer Clinical Trial page.